文献速递消化内镜

结肠镜检查肠道准备失败后两种清肠方案的随机对照研究

A Multicenter Randomized Controlled Trial Comparing Two Bowel Cleansing Regimens for Colonoscopy After Failed Bowel Preparation.
PubMed 文献 · Clin Gastroenterol Hepatol · 2021-07-10

这项多中心、内镜医师盲法随机对照试验纳入196例既往肠道准备失败的患者,比较分次PEG 2+2L+比沙可啶与PEG 4+2L+比沙可啶方案。两组充分肠道准备率、腺瘤检出率及盲肠插管率均无显著差异,但低剂量组重复意愿更高。

要点

  • PEG 2+2L+比沙可啶方案效果不劣于PEG 4+2L方案
  • 两组腺瘤检出率与盲肠插管率无显著差异
  • 低剂量方案患者重复意愿更高

核心结论

  • 分次4L PEG联合15mg比沙可啶及饮食限制对既往肠道准备失败患者的疗效与更高容量方案相似,且重复意愿更高。

研究设计与样本

  • 多中心、内镜医师盲法随机对照试验,在加拿大4个学术中心纳入196例既往肠道准备失败患者。
  • 患者随机接受分次PEG 2+2L+比沙可啶或PEG 4+2L+比沙可啶方案。

主要发现

  • PEG 2+2L+比沙可啶组与PEG 4+2L+比沙可啶组的充分肠道准备率分别为91.2%与87.6%,差异无统计学意义(P = .44)。
  • 平均腺瘤检出率分别为37.4%与31.5%(P = .41),进展期腺瘤检出率分别为18.7%与11.2%(P = .16),无蒂锯齿状病变检出率分别为8.8%与5.6%(P = .41)。
  • 盲肠插管率分别为96.7%与92.1%(P = .19)。
  • PEG 2+2L+比沙可啶组重复肠道准备的意愿更高(91.2% vs 66.2%;P < .001)。

关键数值与推荐

  • 充分肠道准备定义为波士顿肠道准备量表总分≥6分且所有肠段评分≥2分。
  • 两组方案均在检查前第3天和第2天采用低纤维饮食,检查前一天和检查当天早晨采用清流质饮食。

临床怎么用

  • 对既往肠道准备失败且依从性良好的患者,可考虑使用分次4L PEG联合15mg比沙可啶及饮食限制方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Failed bowel preparation for colonoscopy occurs commonly, but the optimal regimen for the subsequent attempt is unknown. High-volume preparations often are used but are not well studied. The objective of this study was to compare the efficacy, tolerability, and safety of 2 regimens for use after failed bowel preparation. METHODS: A multicenter, endoscopist-blinded randomized controlled trial was conducted in patients who previously failed bowel preparation despite adequate compliance. Patients were randomized to 1 of 2 split polyethylene glycol (PEG) regimens, preceded by 15 mg bisacodyl: PEG 2 L the evening before and 2 L the day of colonoscopy (PEG 2+2L+bisacodyl), or 4 L and 2 L (PEG 4+2L+bisacodyl). All patients followed a low-fiber diet on both the third and second day before the procedure, followed by a clear fluid diet the day before and the morning of the colonoscopy. The primary outcome was adequate bowel preparation, defined as a Boston Bowel Preparation Scale total score of 6 or higher, with all segment scores of 2 or higher. Secondary outcomes included adenoma detection rate, advanced adenoma detection rate, sessile serrated lesion detection, cecal intubation rate, tolerability, and adverse events. RESULTS: A total of 196 subjects were randomized at 4 academic centers in Canada (mean age, 60.7 y; SD, 11.4 y; 44.9% were women). There were no significant differences between the PEG 2+2L+bisacodyl and the PEG 4+2L+bisacodyl groups in achieving adequate bowel preparation (91.2% vs 87.6%; P = .44). There were no significant differences with regard to mean adenoma detection rate (37.4% vs 31.5%; P = .41), advanced adenoma detection rate (18.7% vs 11.2%; P = .16), sessile serrated lesion detection (8.8% vs 5.6%; P = .41), and cecal intubation rate (96.7% vs 92.1%; P = .19). The 2 regimens were similarly well tolerated, but PEG 2+2L+bisacodyl was associated with a higher willingness to repeat the bowel preparation (91.2% vs 66.2%; P < .001). CONCLUSIONS: Split-dose 4 L-PEG with 15 mg bisacodyl, along with dietary restrictions, has similar efficacy as a higher-volume preparation, and should be considered for patients who previously failed bowel preparation (ClinicalTrials.gov number, NCT02976805).

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Sey MSL, Von Renteln D, Sultanian R, et al. A Multicenter Randomized Controlled Trial Comparing Two Bowel Cleansing Regimens for Colonoscopy After Failed Bowel Preparation. Clin Gastroenterol Hepatol. 2021. PMID: 34256147. doi:10.1016/j.cgh.2021.07.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。